We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+7.29%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$22.1B
AUM Growth
+$302M
(+1.4%)
Cap. Flow
-$1.3B
Cap. Flow
% of AUM
-5.9%
Top 10 Holdings %
Top 10 Hldgs %
11.41%
Holding
3,562
New
1,146
Increased
641
Reduced
606
Closed
971
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$148M |
| 2 |
Netflix
NFLX
|
+$119M |
| 3 |
Airbnb
ABNB
|
+$111M |
| 4 |
XYZ
Block Inc
XYZ
|
+$89.5M |
| 5 |
Danaher
DHR
|
+$88.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Charles River Laboratories
CRL
|
+$212M |
| 2 |
Alibaba
BABA
|
+$172M |
| 3 |
Zoetis
ZTS
|
+$133M |
| 4 |
TransUnion
TRU
|
+$124M |
| 5 |
Baidu
BIDU
|
+$111M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.88% |
| 2 | Financials | 13.4% |
| 3 | Consumer Discretionary | 12.06% |
| 4 | Technology | 11.2% |
| 5 | Communication Services | 8.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
API
376
Agora
API
$326M
| $12.6M | 0.06% |
299,880
+214,056
| +249% | +$9.9M |
|
377
CALL
State Street Energy Select Sector SPDR ETF
XLE
$39.5B
| $12.5M | 0.06% |
464,600
+361,600
| +351% | +$9.4M |
|
378
Digital Realty Trust
DLR
$73.7B
| $12.5M | 0.06% |
82,906
+77,523
| +1,440% | +$11.7M |
|
379
Invesco
IVZ
$13.3B
| $12.5M | 0.06% |
465,966
+327,305
| +236% | +$8.92M |
|
380
VF Corp
VFC
$6.68B
| $12.4M | 0.06% |
150,730
-309,163
| -67% | -$25.8M |
|
|
ELIQ
381
DELISTED
Electriq Power Holdings, Inc.
ELIQ
| $12.3M | 0.06% |
1,275,896
+84,053
| +7% | +$817K |
|
382
Zebra Technologies
ZBRA
$12.4B
| $12.3M | 0.06% |
23,283
+17,858
| +329% | +$8.9M |
|
383
Fortune Brands Innovations
FBIN
$6.12B
| $12.3M | 0.06% |
+144,293
| New | +$12.6M |
|
384
Burlington
BURL
$22B
| $12.3M | 0.06% |
38,131
+28,422
| +293% | +$9.05M |
|
|
KYNB
385
Kyntra Bio
KYNB
$28.5M
| $12.3M | 0.06% |
+18,434
| New | +$10.6M |
|
|
CSTA
386
DELISTED
Constellation Acquisition Corp I
CSTA
| $12.2M | 0.06% |
1,249,989
| – | – |
|
387
Teledyne Technologies
TDY
$30.4B
| $12.2M | 0.06% |
29,160
+26,046
| +836% | +$11.1M |
|
388
SPDR Gold Trust
GLD
$131B
| $12.2M | 0.06% |
73,650
-27,175
| -27% | -$4.62M |
|
|
SEAH
389
DELISTED
Sports Entertainment Acquisition Corp.
SEAH
| $12.2M | 0.06% |
1,207,689
| – | – |
|
|
TWLV
390
DELISTED
Twelve Seas Investment Company II Class A Common Stock
TWLV
| $12.1M | 0.05% |
+1,256,406
| New | +$12.2M |
|
391
Intellia Therapeutics
NTLA
$1.5B
| $12.1M | 0.05% |
74,744
+59,835
| +401% | +$4.66M |
|
392
MGM Resorts International
MGM
$11.7B
| $12.1M | 0.05% |
283,710
+84,730
| +43% | +$3.51M |
|
393
Yeti Holdings
YETI
$3.82B
| $12.1M | 0.05% |
131,627
-84,930
| -39% | -$7.37M |
|
|
AISP
394
Airship AI Holdings
AISP
$69.2M
| $12.1M | 0.05% |
+1,249,994
| New | +$12.1M |
|
395
Envoy Medical
COCH
$51M
| $12M | 0.05% |
+1,240,872
| New | +$12.1M |
|
396
Chipotle Mexican Grill
CMG
$40.8B
| $12M | 0.05% |
387,750
+273,900
| +241% | +$7.82M |
|
|
SPAQ
397
DELISTED
Spartan Acquisition Corp. III
SPAQ
| $12M | 0.05% |
+1,222,094
| New | +$12M |
|
|
MGI
398
DELISTED
MoneyGram International, Inc. New
MGI
| $11.9M | 0.05% |
1,183,858
+782,718
| +195% | +$6.6M |
|
399
ScottsMiracle-Gro
SMG
$4.03B
| $11.9M | 0.05% |
+62,084
| New | +$13.7M |
|
400
Allogene Therapeutics
ALLO
$601M
| $11.9M | 0.05% |
+456,591
| New | +$13M |
|
Similar funds
Marshall Wace's Q2 2021 Portfolio in Review
As of Q2 2021, Marshall Wace held 3,562 positions worth $22.1B, up 1.4% from $21.8B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Marshall Wace withdrew a net $1.3B in Q2 2021, closing 971 positions and reducing 606 holdings. Its most notable exit was Pinterest, an estimated $88.8M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 20% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Marshall Wace opened a new position in West Pharmaceutical worth $55.8M.
- Marshall Wace's largest Q2 2021 buy was West Pharmaceutical: 155,316 shares worth $55.8M.
- Marshall Wace added most to Biogen in Q2 2021, an estimated $148M increase.
- Marshall Wace's biggest Q2 2021 reduction was Charles River Laboratories, cutting an estimated $212M.
- Marshall Wace fully exited Pinterest in Q2 2021, selling an estimated $88.8M.
- Marshall Wace's ten largest holdings make up 11% of its $22.1B portfolio in Q2 2021.
- Marshall Wace opened 1,146 new positions and closed 971 in Q2 2021.
- Marshall Wace's portfolio value rose 1.4% quarter-over-quarter to $22.1B.
Based on Marshall Wace's 13F filing for Q2 2021, filed 13 Aug 2021.